These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. Camps P, Formosa X, Galdeano C, Gómez T, Muñoz-Torrero D, Scarpellini M, Viayna E, Badia A, Clos MV, Camins A, Pallàs M, Bartolini M, Mancini F, Andrisano V, Estelrich J, Lizondo M, Bidon-Chanal A, Luque FJ. J Med Chem; 2008 Jun 26; 51(12):3588-98. PubMed ID: 18517184 [Abstract] [Full Text] [Related]
24. Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors. Leonetti F, Catto M, Nicolotti O, Pisani L, Cappa A, Stefanachi A, Carotti A. Bioorg Med Chem; 2008 Aug 01; 16(15):7450-6. PubMed ID: 18585045 [Abstract] [Full Text] [Related]
28. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation. Luo W, Li YP, He Y, Huang SL, Tan JH, Ou TM, Li D, Gu LQ, Huang ZS. Bioorg Med Chem; 2011 Jan 15; 19(2):763-70. PubMed ID: 21211982 [Abstract] [Full Text] [Related]
29. Synthesis and biological evaluation of 3,6-diaryl-7H-thiazolo[3,2-b] [1,2,4]triazin-7-one derivatives as acetylcholinesterase inhibitors. Jin Z, Yang L, Liu SJ, Wang J, Li S, Lin HQ, Wan DC, Hu C. Arch Pharm Res; 2010 Oct 15; 33(10):1641-9. PubMed ID: 21052939 [Abstract] [Full Text] [Related]
30. Design, synthesis and evaluation of novel 2-(aminoalkyl)-isoindoline-1,3-dione derivatives as dual-binding site acetylcholinesterase inhibitors. Ignasik M, Bajda M, Guzior N, Prinz M, Holzgrabe U, Malawska B. Arch Pharm (Weinheim); 2012 Jul 15; 345(7):509-16. PubMed ID: 22467516 [Abstract] [Full Text] [Related]
31. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues. Bolognesi ML, Bartolini M, Cavalli A, Andrisano V, Rosini M, Minarini A, Melchiorre C. J Med Chem; 2004 Nov 18; 47(24):5945-52. PubMed ID: 15537349 [Abstract] [Full Text] [Related]
32. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications. Musilek K, Komloova M, Zavadova V, Holas O, Hrabinova M, Pohanka M, Dohnal V, Nachon F, Dolezal M, Kuca K, Jung YS. Bioorg Med Chem Lett; 2010 Mar 01; 20(5):1763-6. PubMed ID: 20138518 [Abstract] [Full Text] [Related]
33. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds. Camps P, Formosa X, Galdeano C, Muñoz-Torrero D, Ramírez L, Gómez E, Isambert N, Lavilla R, Badia A, Clos MV, Bartolini M, Mancini F, Andrisano V, Arce MP, Rodríguez-Franco MI, Huertas O, Dafni T, Luque FJ. J Med Chem; 2009 Sep 10; 52(17):5365-79. PubMed ID: 19663388 [Abstract] [Full Text] [Related]
34. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase. Huang L, Luo Z, He F, Lu J, Li X. Bioorg Med Chem; 2010 Jun 15; 18(12):4475-84. PubMed ID: 20471843 [Abstract] [Full Text] [Related]
35. Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives. Yan J, Sun L, Wu G, Yi P, Yang F, Zhou L, Zhang X, Li Z, Yang X, Luo H, Qiu M. Bioorg Med Chem; 2009 Oct 01; 17(19):6937-41. PubMed ID: 19726199 [Abstract] [Full Text] [Related]
36. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase. Grigoryan HA, Hambardzumyan AA, Mkrtchyan MV, Topuzyan VO, Halebyan GP, Asatryan RS. Chem Biol Interact; 2008 Jan 10; 171(1):108-16. PubMed ID: 17980356 [Abstract] [Full Text] [Related]
37. Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: structure-activity relationships and molecular modeling studies. Liu J, Dumontet V, Simonin AL, Iorga BI, Guerineau V, Litaudon M, Nguyen VH, Gueritte F. J Nat Prod; 2011 Oct 28; 74(10):2081-8. PubMed ID: 21939219 [Abstract] [Full Text] [Related]
38. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P. Bioorg Med Chem; 2012 Nov 15; 20(22):6669-79. PubMed ID: 23062825 [Abstract] [Full Text] [Related]
39. Synthesis of α-oxycarbanilinophosphonates and their anticholinesterase activities: the most potent derivative is bound to the peripheral site of acetylcholinesterase. Kaboudin B, Emadi S, Faghihi MR, Fallahi M, Sheikh-Hasani V. J Enzyme Inhib Med Chem; 2013 Jun 15; 28(3):576-82. PubMed ID: 22397393 [Abstract] [Full Text] [Related]
40. New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors. Loh ZH, Kwong HC, Lam KW, Teh SS, Ee GCL, Quah CK, Ho ASH, Mah SH. J Enzyme Inhib Med Chem; 2021 Dec 15; 36(1):627-639. PubMed ID: 33557647 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]